Search from website

News

19 April 2023

RBP4 as a Biomarker for Metabolic Diseases

04 April 2023

Understanding HIV Diagnostic Testing: The Role of p24 Antibodies

20 March 2023

PRESS RELEASE: Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies

08 February 2023

PRESS RELEASE: InvestEU: EIB agrees to €18 million loan to Estonian biotech Icosagen for innovative R&D technologies and new cGMP production facility

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart